CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-1 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-1 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on tough blood cancers
Disease control OngoingThis study is testing whether adding a new oral drug called seclidemstat to a standard chemotherapy (azacitidine) is safe and effective for patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The trial will first find the best dose and then se…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New Two-Drug attack on tough blood cancers
Disease control OngoingThis study is testing a two-drug combination to control chronic myelomonocytic leukemia and related blood cancers. It aims to find the safest, most effective dose and see how well the treatment works. The treatment pairs a targeted drug that seeks out cancer cells with a standard…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Race to find better treatment for aggressive blood disorders
Disease control OngoingThis study aims to find the most effective drug combination for treating higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), which are serious blood and bone marrow disorders. Researchers are comparing a standard chemotherapy drug (azacitidine)…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC